Total Payments
$73,846
2024 Payments
$44,793
Companies
13
Transactions
102
Medicare Patients
1,727
Medicare Billing
$234,232
Payment Breakdown by Category
Other$65,125 (88.2%)
Food & Beverage$5,299 (7.2%)
Travel$3,422 (4.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $40,125 | 24 | 54.3% |
| Grant | $25,000 | 1 | 33.9% |
| Food and Beverage | $5,299 | 67 | 7.2% |
| Travel and Lodging | $3,422 | 10 | 4.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $38,436 | 43 | $0 (2024) |
| Boston Scientific Corporation | $32,549 | 30 | $0 (2024) |
| Olympus Corporation of the Americas | $960.08 | 6 | $0 (2017) |
| CONMED Corporation | $498.60 | 5 | $0 (2019) |
| Cook Medical LLC | $378.88 | 5 | $0 (2024) |
| Olympus America Inc. | $322.70 | 3 | $0 (2020) |
| Apollo Endosurgery US Inc | $239.61 | 3 | $0 (2022) |
| Ethicon US, LLC | $125.00 | 1 | $0 (2018) |
| AbbVie, Inc. | $112.62 | 2 | $0 (2019) |
| Micro-tech Endoscopy USA, Inc. | $100.05 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $44,793 | 59 | Lilly USA, LLC ($38,436) |
| 2023 | $920.02 | 8 | Boston Scientific Corporation ($848.10) |
| 2022 | $646.72 | 8 | Boston Scientific Corporation ($494.03) |
| 2021 | $333.11 | 5 | BOSTON SCIENTIFIC CORPORATION ($146.14) |
| 2020 | $166.30 | 3 | Boston Scientific Corporation ($110.46) |
| 2019 | $25,485 | 7 | Boston Scientific Corporation ($25,000) |
| 2018 | $445.37 | 5 | CONMED Corporation ($307.87) |
| 2017 | $1,057 | 7 | Olympus Corporation of the Americas ($960.08) |
All Payment Transactions
102 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $165.70 | General |
| Category: EXALT Model D_ENDO | ||||||
| 12/19/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: Obesity | ||||||
| 12/19/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: Obesity | ||||||
| 12/16/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: Obesity | ||||||
| 12/13/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: Obesity | ||||||
| 12/06/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: Obesity | ||||||
| 11/12/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $625.00 | General |
| Category: Obesity | ||||||
| 10/25/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: Obesity | ||||||
| 10/25/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: Obesity | ||||||
| 10/18/2024 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: EXALT Model D_ENDO | ||||||
| 10/08/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: Obesity | ||||||
| 10/04/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: Obesity | ||||||
| 08/29/2024 | Boston Scientific Corporation | APOLLO ESG System (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: APOLLO ESG System_ENDO | ||||||
| 08/29/2024 | Boston Scientific Corporation | APOLLO ESG System (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: APOLLO ESG System_ENDO | ||||||
| 08/28/2024 | Cook Medical LLC | ECHOTIP INSIGHT (Device) | Food and Beverage | Cash or cash equivalent | $106.37 | General |
| Category: Endoscopy | ||||||
| 08/22/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Obesity | ||||||
| 08/22/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
| Category: Obesity | ||||||
| 08/20/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $787.79 | General |
| 08/20/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: Obesity | ||||||
| 08/10/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $41.02 | General |
| 08/09/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $18.97 | General |
| 06/26/2024 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $161.98 | General |
| Category: EXALT Model D_ENDO | ||||||
| 06/26/2024 | Boston Scientific Corporation | Apollo ESG NXT System (Device) | Food and Beverage | In-kind items and services | $96.26 | General |
| Category: Apollo ESG NXT System_ENDO | ||||||
| 05/02/2024 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $166.83 | General |
| Category: EXALT Model D_ENDO | ||||||
| 04/11/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 658 | 733 | $1.0M | $95,877 |
| 2022 | 20 | 516 | 568 | $697,006 | $65,124 |
| 2021 | 15 | 337 | 395 | $475,557 | $46,240 |
| 2020 | 13 | 216 | 254 | $220,398 | $26,992 |
Total Patients
1,727
Total Services
1,950
Medicare Billing
$234,232
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 68 | 69 | $190,840 | $13,331 | 7.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 107 | $91,806 | $11,756 | 12.8% |
| 45390 | Removal of large bowel tissue using a flexible endoscope | Facility | 2023 | 27 | 29 | $45,747 | $8,212 | 18.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 54 | 54 | $58,590 | $7,651 | 13.1% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 38 | 39 | $60,352 | $6,989 | 11.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 48 | 67 | $45,560 | $6,751 | 14.8% |
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 33 | 34 | $71,600 | $6,698 | 9.4% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope | Facility | 2023 | 15 | 18 | $42,500 | $6,207 | 14.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 34 | 35 | $46,200 | $5,199 | 11.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 26 | 30 | $28,800 | $4,463 | 15.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 65 | 68 | $125,108 | $3,712 | 3.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 39 | 41 | $99,753 | $3,542 | 3.6% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2023 | 13 | 16 | $41,104 | $2,469 | 6.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 12 | 12 | $23,895 | $2,161 | 9.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 27 | 28 | $13,160 | $1,900 | 14.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 25 | $12,700 | $1,523 | 12.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 14 | 15 | $7,114 | $1,397 | 19.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $9,790 | $1,225 | 12.5% |
| 74328 | Review by radiologist of image from tube placement into bile duct using an endoscope | Facility | 2023 | 27 | 35 | $6,895 | $693.80 | 10.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 75 | 86 | $73,788 | $9,039 | 12.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 40 | 41 | $104,509 | $6,964 | 6.7% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope | Facility | 2022 | 15 | 20 | $43,620 | $6,497 | 14.9% |
| 45390 | Removal of large bowel tissue using a flexible endoscope | Facility | 2022 | 22 | 22 | $34,408 | $6,194 | 18.0% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 35 | 35 | $48,300 | $5,793 | 12.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 43 | 43 | $46,655 | $4,982 | 10.7% |
About Dr. Danny Issa, MD
Dr. Danny Issa, MD is a Gastroenterology healthcare provider based in West Hills, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/11/2012. The National Provider Identifier (NPI) number assigned to this provider is 1750631396.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Danny Issa, MD has received a total of $73,846 in payments from pharmaceutical and medical device companies, with $44,793 received in 2024. These payments were reported across 102 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($40,125).
As a Medicare-enrolled provider, Issa has provided services to 1,727 Medicare beneficiaries, totaling 1,950 services with total Medicare billing of $234,232. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location West Hills, CA
- Active Since 09/11/2012
- Last Updated 10/31/2019
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1750631396
Products in Payments
- ZEPBOUND (Drug) $29,056
- GENERAL BILIARY DEVICES (Device) $25,000
- APOLLO ESG System (Device) $5,100
- EXALT Model D (Device) $1,346
- EVIS EXERA (Device) $779.80
- Olympus EMR & ESD Devices (Device) $325.14
- CONMED Biliary (Device) $295.37
- OverStitch Endoscopic Suturing System (Device) $239.61
- HEMOSPRAY (Device) $191.03
- CONMED BILIARY (Device) $190.73
- SpyGlass (Device) $183.89
- Olympus Biliary Devices (Device) $177.84
- OverStitch NXT Endoscopic Suturing System (Device) $138.99
- LINX Reflux Management System (Device) $125.00
- EXALT (Device) $120.53
- EXALT BX 2 (Device) $110.46
- ECHOTIP INSIGHT (Device) $106.37
- All Products (Device) $100.05
- XIFAXAN (Drug) $99.96
- Apollo ESG NXT System (Device) $96.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in West Hills
Dr. Mona Rezapour, M.d, M.D
Gastroenterology — Payments: $259,648
Gastroenterology $259,648
Calin Arimie, Md, MD
Gastroenterology — Payments: $13,837
Gastroenterology $13,837
Dr. Jonathan Matthew, Md, MD
Gastroenterology — Payments: $8,392
Gastroenterology $8,392
Dr. Gerald Rothman, Md, MD
Gastroenterology — Payments: $7,284
Gastroenterology $7,284
Dr. Stephen Herr, Md, MD
Gastroenterology — Payments: $4,102
Gastroenterology $4,102
Craig Gluckman, Md, MD
Gastroenterology — Payments: $2,008
Gastroenterology $2,008